NASDAQ:CDTX
Cidara Therapeutics, Inc.
- Stock
Last Close
12.95
30/08 20:00
Market Cap
51.64M
Beta: 1.34
Volume Today
40.58K
Avg: 3.19M
PE Ratio
−1.95
PFCF: −2.35
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.34M - | -11.89M 784.97% | -32.19M 170.67% | -48.16M 49.61% | -55.73M 15.70% | -59.02M 5.90% | -41.09M 30.37% | -72.11M 75.49% | -42.47M 41.11% | -29.80M 29.83% | -22.93M 23.05% | |
depreciation and amortization | 179K - | 461K 157.54% | 732K 58.79% | 667K 8.88% | 523K 21.59% | 375K 28.30% | 229K 38.93% | -1.23M 637.12% | 1.23M 199.59% | 118K 90.37% | ||
deferred income tax | -42K - | -176K 319.05% | -33K 81.25% | -3.61M 10,836.36% | -411K 88.61% | |||||||
stock based compensation | 11K - | 232K 2,009.09% | 3.03M 1,207.33% | 4.34M 43.22% | 5.71M 31.54% | 5.71M 0.07% | 5.07M 11.16% | 4.09M 19.38% | 4.01M 1.86% | 3.53M 12.01% | ||
change in working capital | 23K - | 1.89M 8,134.78% | 2.71M 42.87% | 3.48M 28.60% | -579K 116.64% | -399K 31.09% | 7.49M 1,976.44% | 13.36M 78.44% | 14.44M 8.05% | -3.43M 123.77% | -13.51M 293.74% | |
accounts receivables | -10K - | -11.16M 111,550% | 5.82M 152.12% | -477K 108.20% | -10.41M 2,083.02% | |||||||
inventory | 10K - | -6.59M 66,010% | 1.09M 116.58% | -6.10M - | ||||||||
accounts payables | 2.14M - | 1.91M 10.73% | 642K 66.44% | -59K 109.19% | -784K 1,228.81% | 6.59M 940.69% | -1.09M 116.58% | -2.37M 116.93% | ||||
other working capital | 23K - | 1.89M 8,134.78% | 563K 70.27% | 1.57M 178.33% | -1.22M 177.92% | -340K 72.15% | 8.27M 2,532.65% | 24.52M 196.52% | 8.62M 64.86% | -584K 106.78% | 3.00M 613.18% | |
other non cash items | 262K - | 1.88M 617.18% | 76K 95.96% | 14K 81.58% | 50K 257.14% | 86K 72% | 36K 58.14% | 21K 41.67% | 15K 28.57% | 1K 93.33% | 13.89M 1,389,300% | |
net cash provided by operating activities | -1.05M - | -7.71M 635.69% | -25.96M 236.69% | -39.77M 53.21% | -49.91M 25.49% | -56.70M 13.62% | -28.53M 49.68% | -54.41M 90.70% | -25.23M 53.63% | -28.47M 12.84% | -22.43M 21.22% | |
investments in property plant and equipment | -991K - | -1.17M 18.06% | -401K 65.73% | -306K 23.69% | -177K 42.16% | -35K 80.23% | -186K 431.43% | -41K 77.96% | -118K 187.80% | -505K 327.97% | ||
acquisitions net | ||||||||||||
purchases of investments | -54.92M - | -69.62M 26.77% | -19.52M 71.96% | -14.55M 25.48% | ||||||||
sales maturities of investments | 10M - | 95.50M 855.00% | 24.30M 74.55% | 29.03M 19.45% | ||||||||
other investing activites | ||||||||||||
net cash used for investing activites | -991K - | -46.09M 4,550.66% | 25.48M 155.29% | 4.47M 82.45% | 14.30M 219.86% | -35K 100.24% | -186K 431.43% | -41K 77.96% | -118K 187.80% | -505K 327.97% | ||
debt repayment | -2.96M - | -4.44M 49.98% | -2.59M 41.65% | |||||||||
common stock issued | 10K - | 69.50M 694,950% | 26.62M 61.70% | 20.73M 22.11% | 6.44M 68.94% | 14.30M 122.00% | 40.23M 181.37% | 49.03M 21.90% | 2.36M 95.18% | |||
common stock repurchased | 175K - | -79K 145.14% | 9.01M - | |||||||||
dividends paid | ||||||||||||
other financing activites | 1.23M - | 31.30M 2,440.75% | 42.31M 35.16% | 10.30M 75.66% | 228K 97.79% | 49.71M 21,703.95% | -9.03M 118.17% | 14K 100.16% | 6K 57.14% | -720K 12,100% | 25.98M 3,708.89% | |
net cash used provided by financing activities | 1.23M - | 31.31M 2,441.56% | 111.81M 257.09% | 37.09M 66.82% | 20.88M 43.70% | 56.15M 168.88% | 14.27M 74.58% | 37.28M 161.18% | 44.60M 19.63% | -951K 102.13% | 25.98M 2,832.28% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 184K - | 22.61M 12,188.59% | 39.77M 75.87% | 22.80M 42.65% | -24.55M 207.67% | 13.75M 155.99% | -14.29M 203.96% | -17.32M 21.16% | 19.32M 211.58% | -29.54M 252.88% | 3.05M 110.31% | |
cash at beginning of period | 1K - | 185K 18,400% | 22.80M 12,222.16% | 62.56M 174.44% | 85.37M 36.45% | 60.81M 28.76% | 74.56M 22.61% | 60.27M 19.17% | 42.95M 28.74% | 62.27M 44.99% | 32.73M 47.44% | |
cash at end of period | 185K - | 22.80M 12,222.16% | 62.56M 174.44% | 85.37M 36.45% | 60.81M 28.76% | 74.56M 22.61% | 60.27M 19.17% | 42.95M 28.74% | 62.27M 44.99% | 32.73M 47.44% | 35.78M 9.31% | |
operating cash flow | -1.05M - | -7.71M 635.69% | -25.96M 236.69% | -39.77M 53.21% | -49.91M 25.49% | -56.70M 13.62% | -28.53M 49.68% | -54.41M 90.70% | -25.23M 53.63% | -28.47M 12.84% | -22.43M 21.22% | |
capital expenditure | -991K - | -1.17M 18.06% | -401K 65.73% | -306K 23.69% | -177K 42.16% | -35K 80.23% | -186K 431.43% | -41K 77.96% | -118K 187.80% | -505K 327.97% | ||
free cash flow | -1.05M - | -8.70M 730.25% | -27.13M 211.79% | -40.17M 48.08% | -50.22M 25% | -56.88M 13.28% | -28.57M 49.78% | -54.60M 91.12% | -25.27M 53.71% | -28.59M 13.13% | -22.94M 19.78% |
All numbers in USD (except ratios and percentages)